Published in Parasitol Res on June 01, 1998
The monocyte locomotion inhibitory factor produced by Entamoeba histolytica inhibits induced nitric oxide production in human leukocytes. Parasitol Res (2003) 0.89
Could the homologous sequence of anti-inflammatory pentapeptide (MLIF) produced by Entamoeba histolytica in the N protein of rabies virus affect the inflammatory process? Parasitol Res (2005) 0.79
Anti-inflammatory defense mechanisms of Entamoeba histolytica. Inflamm Res (2010) 0.78
Chicken embryo model for type III group B beta-hemolytic streptococcal septicemia. Infect Immun (1978) 1.53
Yeast transcript elongation factor (TFIIS), structure and function. II: RNA polymerase binding, transcript cleavage, and read-through. J Biol Chem (1998) 1.35
Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine release. J Neurosci (2001) 1.34
Perinatal immunity to group B beta-hemolytic streptococcus type Ia. J Infect Dis (1977) 1.12
Human immunity to group B streptococci measured by indirect immunofluorescence: correlation with protection in chick embryos. J Infect Dis (1979) 1.04
High frequency of association of rheumatic/autoimmune diseases and untreated male hypogonadism with severe testicular dysfunction. Arthritis Res (2001) 1.00
Bactericidal capacity of newborn phagocytes against group B beta-hemolytic streptococci. Infect Immun (1981) 0.93
Inhibition of human monocyte locomotion by products of axenically grown E. histolytica. Parasite Immunol (1985) 0.91
The monocyte locomotion inhibitory factor produced by Entamoeba histolytica inhibits induced nitric oxide production in human leukocytes. Parasitol Res (2003) 0.89
Colonization of Mexican pregnant women with group B streptococcus. J Infect Dis (1981) 0.88
Defective polymorphonuclear chemotaxis in patients with Turner's syndrome (45,X). Clin Genet (1988) 0.87
Protective value of gamma globulin preparations against group B streptococcal infections in chick embryos and mice. Pediatr Res (1980) 0.86
HLA-B27 and ankylosing spondylitis in the Mexican Mestizo population. Tissue Antigens (1984) 0.84
Group B streptococcal long-chain reaction. Infect Immun (1977) 0.83
Reversible neutrophil defect in ataxia telangiectasia. Pediatrics (1972) 0.82
Toxicity of a commercial herbicide containing terbutryn and triasulfuron to seabream (Sparus aurata L.) larvae: a comparison with the Microtox test. Ecotoxicol Environ Saf (2004) 0.82
Enhancement of antigen-induced leukocyte histamine release by a mononuclear cell--derived factor. J Allergy Clin Immunol (1978) 0.82
Intradermal reactions to an antigen (histolyticin) obtained from axenically cultivated Entamoeba histolytica. Trop Geogr Med (1972) 0.81
Transgenic tobacco plants that overexpress alfalfa NADH-glutamate synthase have higher carbon and nitrogen content. J Exp Bot (2001) 0.81
Assessing the value of atomoxetine in treating children and adolescents with ADHD in the UK. Int J Clin Pract (2009) 0.81
Defective monocyte chemotaxis in children with Down's syndrome. Pediatr Res (1983) 0.79
Increased frequency of HLA-DR3 and complotype SC01 in Mexican mestizo patients with amoebic abscess of the liver. Parasite Immunol (1991) 0.79
Effect of Fusarium toxins, T2-toxin and diacetoxyscirpenol on murine T-independent immune responses. Immunology (1981) 0.79
The ultrastructure of Entamoeba histolytica locomotion. Arch Med Res (1996) 0.78
Inhibition of contact cutaneous delayed hypersensitivity reactions to DNBC in guinea pigs by the monocyte locomotion inhibitory factor (MLIF) produced by axenically grown Entamoeba histolytica. Arch Med Res (1997) 0.78
Entamoeba histolytica: antibody response to recent and past invasive events. Ann Trop Med Parasitol (1993) 0.78
An enzyme-linked immunosorbent assay (ELISA) for human IgG antibody to the type Ia polysaccharide of group B streptococcus. J Lab Clin Med (1982) 0.78
Immunological aspects of group B streptococcal infections. Infection (1978) 0.78
[Phagocytosis in patients with splenectomy]. Arch Invest Med (Mex) (1975) 0.78
Histological and histochemical characteristics of the lymphocystis disease in gilthead seabream, Sparus aurata L. from the south-atlantic coast of Spain. Eur J Histochem (1996) 0.78
Comparative toxic effects of formulated simazine on Vibrio fischeri and gilthead seabream (Sparus aurata L.) larvae. Chemosphere (2004) 0.78
Serum IgD concentration in pregnant women. Clin Immunol Immunopathol (1975) 0.78
Histochemical study of lymphocystis disease in skin of gilthead seabream, Sparus aurata L. Histol Histopathol (1998) 0.77
Does the eosinophil have a protective role in amebiasis? Mem Inst Oswaldo Cruz (1997) 0.77
Immune phenomena in amebiasis. Surv Immunol Res (1984) 0.77
Chronic bullous dermatosis of childhood. Arch Dermatol (1977) 0.77
Effect of the monocyte locomotion inhibitory factor (MLIF) produced by Entamoeba histolytica upon the respiratory burst of human leukocytes. Arch Med Res (1992) 0.77
Cyclic nucleotide changes induced in human leukocytes by a product of axenically grown Entamoeba histolytica that inhibits human monocyte locomotion. Parasitol Res (1995) 0.77
Quantitative nitrobluetetrazolium reduction by normal newborn monocytes. J Pediatr (1977) 0.77
HLA antigens associated to amoebic abscess of the liver in Mexican mestizos. Parasite Immunol (1987) 0.77
Antigen induced eosinophilia protects gerbils (Meriones unguiculatus) against experimental amebic abscess of the liver. Arch Med Res (1995) 0.77
Two-dimensional echo Doppler findings in juvenile and adult onset ankylosing spondylitis with long-term disease. Angiology (2001) 0.77
Histochemical study of skin and gills of Senegal sole, Solea senegalensis larvae and adults. Histol Histopathol (1998) 0.77
An estimation of the long-term clinical and economic benefits of insulin lispro in Type 1 diabetes in the UK. Diabet Med (2009) 0.77
The role of mannose in the receptor of the monocyte locomotion inhibitory factor produced by Entamoeba histolytica. Parasitol Res (1991) 0.76
Production of the monocyte locomotion inhibitory factor (MLIF) by axenically grown Entamoeba histolytica: synthesis or degradation? Arch Med Res (1997) 0.76
Ultrastructural changes associated with the inhibition of monocyte chemotaxis caused by products of axenically grown Entamoeba histolytica. Lab Invest (1987) 0.76
The destruction of virulent Entamoeba histolytica by activated human eosinophils. Parasite Immunol (1992) 0.76
HLA characterization in adult asymptomatic cyst passers of Entamoeba histolytica/E. dispar. Parasitol Res (1999) 0.76
[Monocyte locomotion inhibiting factor (MLIF) produced by E. histolytica induces an increase of cAMP in human monocytes]. Arch Invest Med (Mex) (1990) 0.76
The monocyte locomotion inhibitory factor (MLIF) produced by axenically grown Entamoeba histolytica fails to affect the locomotion and the respiratory burst of human eosinophils in vitro. Arch Med Res (1997) 0.75
In vitro studies on the interaction of human monocytes and the monocyte locomotion inhibitory factor produced by E. histolytica. Arch Invest Med (Mex) (1986) 0.75
Synovial cysts in juvenile rheumatoid arthritis. Ann Rheum Dis (1978) 0.75
[Renal transplant. Experience in 320 cases]. Angiologia (1987) 0.75
Destruction of normal human eosinophils by Entamoeba histolytica. Parasite Immunol (1989) 0.75
Immunologic disorders in children. IMJ Ill Med J (1976) 0.75
Further physicochemical characterization of the monocyte locomotion inhibition factor (MLIF) produced by Entamoeba histolytica. Arch Med Res (1992) 0.75
Chemotaxis. Infection (1980) 0.75
[Significance of the cost assessment method in dialysis and renal transplantation]. Nefrologia (2001) 0.75
[Impact of new methodologies in the study of parasites]. Gac Med Mex (1997) 0.75
Thymosin-induced leukocyte histamine release reaction in an infant with DiGeorge syndrome. Clin Immunol Immunopathol (1979) 0.75
Bactericidal kinetics of newborn polymorphonuclear leukocytes against group B streptococci type III. Infection (1985) 0.75
[Effect of cycloheximide on the inhibition of chemotaxis in human monocytes caused by products of E. histolytica]. Arch Invest Med (Mex) (1982) 0.75
In vitro and in vivo effect of heparin, chondroitin, dextran and protamine on the virulence of pseudorabies virus (Suid herpesvirus 1). Arch Invest Med (Mex) (1990) 0.75
Immune consequences of amebiasis. Pediatr Infect Dis (1986) 0.75
Obtention of HLA antigen system typifying monospecific sera. Arch Invest Med (Mex) (1982) 0.75
[Amebiasis. Features of its immunologic behavior]. Rev Gastroenterol Mex (1989) 0.75
[Impact of organ transplantation 40 years after the beginnings]. Gac Med Mex (1996) 0.75
Further characterization of a human monocyte locomotion inhibitory factor produced by axenically grown Entamoeba histolytica. Parasitol Res (1989) 0.75
Incongruent parenthood in a Mexican mestizo population as determined by HLA typing. Arch Invest Med (Mex) (1992) 0.75
[Immunosuppression and blood transfusions in patients with a kidney transplant]. Gac Med Mex (1993) 0.75
Induction of protective immunity against experimental amebic abscess of the liver (EAAL) using the monocyte locomotion inhibitory factor (MLIF) produced by Entamoeba histolytica: a preliminary report. Arch Med Res (2000) 0.75
Increased frequency of HLA-DR3 and complotype SC01 in Mexican Mestizo children with amebic abscess of the liver and summary of our overall HLA-SC01 experience in invasive amebiasis. Arch Med Res (1997) 0.75
Thyrotoxic periodic paralysis in Mexican mestizo patients: a clinical, biochemical and HLA-serological study. Arch Med Res (1999) 0.75
Heavy chain disease, rheumatoid arthritis and cryoglobulinemia. Clin Immunol Immunopathol (1974) 0.75
The killing of Entamoeba histolytica by activated human eosinophils. Arch Med Res (1992) 0.75
Increased frequency of HLA-DR3 in Mexican mestizo pediatric patients with amebic liver abscess (ALA). Arch Med Res (1992) 0.75
Group-B streptococcal infections. Lancet (1979) 0.75
[In vitro liberation of leukocyte histamine caused by amebic antigen and by concanavalin in patients with invasive amebiasis]. Arch Invest Med (Mex) (1982) 0.75
Increased susceptibility to experimental amebic abscess of the liver (EAAL) in gerbils (Meriones unguiculatus) with induced eosinopenia. Arch Med Res (2000) 0.75
[HLA antigens, complement types, and amebic liver abscess in Mexican mestizos]. Arch Invest Med (Mex) (1990) 0.75
Increased leucocyte histamine release by Entamoeba histolytica antigen in patients with amoebic abscess of the liver. Parasite Immunol (1984) 0.75
HLA and nephropathies in Mexican mestizo people. Arch Invest Med (Mex) (1987) 0.75
Amebic lectin stimulation of lymphocytes of Mexican Mestizos recovered from amebic abscess of the liver induces decreased production of IL5 and IL6. Arch Med Res (2000) 0.75
Technetium-99m labeling of human monocytes for chemotactic studies. J Nucl Med (1976) 0.75
How adult beliefs shape the speech communities of a child who has multiple disabilities. Ment Retard (1999) 0.75
[Immunity in the newborn]. Gac Med Mex (1977) 0.75
HLA profile of the Mexican Mestizo population. Tissue Antigens (1981) 0.75
Does serum rheumatoid factor have an influence on the clinical picture of ankylosing spondylitis? Clin Exp Rheumatol (1997) 0.75